Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$14.54 - $27.17 $17.9 Million - $33.4 Million
-1,228,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$22.61 - $34.8 $6.95 Million - $10.7 Million
307,547 Added 33.41%
1,228,000 $42.7 Million
Q2 2020

Aug 14, 2020

BUY
$19.65 - $39.34 $1 Million - $2 Million
50,919 Added 5.86%
920,453 $29.1 Million
Q1 2020

May 15, 2020

BUY
$20.0 - $34.08 $17.4 Million - $29.6 Million
869,534 New
869,534 $19.1 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.77B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.